Final 5-Year Results of the TAXUS II Trial | Zendy

Sigmund Silber | Zendy; Antonio Colombo | Zendy; Adrian Banning | Zendy; Karl Eugen Hauptmann | Zendy; J Drzewiecki | Zendy; Eberhard Grube | Zendy; Dariusz Dudek | Zendy; Donald S. Baim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Final 5-Year Results of the TAXUS II Trial

Author(s) -

Sigmund Silber,

Antonio Colombo,

Adrian Banning,

Karl Eugen Hauptmann,

J Drzewiecki,

Eberhard Grube,

Dariusz Dudek,

Donald S. Baim

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.849877

Subject(s) - taxus , medicine , stent , myocardial infarction , mace , target lesion , bare metal , revascularization , paclitaxel , surgery , randomized controlled trial , clinical trial , restenosis , cardiology , percutaneous coronary intervention , chemotherapy , botany , biology

The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialized slow-release (SR) and an investigation-only moderate-release (MR) polymer-based TAXUS paclitaxel-eluting stent compared with a bare-metal stent for the treatment of de novo coronary lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research